Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx Pharmaceutical Import Records from India — 3 Products, $1.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx — Pharmaceutical Importer Profile (2026) | 3 Products, $1.6M Trade | TransData Nexus

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx

Pharmaceutical Importer · United States · CNS & Psychiatric Focus · $1.6M Total Trade · DGFT Verified

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx is a pharmaceutical importer based in United States with a total trade value of $1.6M across 3 products in 3 therapeutic categories. Based on 31 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx sources from 1 verified Indian supplier, with Torrent Pharmaceuticals Limited accounting for 100.0% of imports.

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx — Import Portfolio & Supplier Network

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Torrent Pharmaceuticals Limited	$2.8M	67	100.0%

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx sources from 1 verified Indian supplier across 18 distinct formulations. The sourcing is highly concentrated — Torrent Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx Import?

Formulation	Value	Ships
Lamotrigine tablets USP 200MG	$387.7K	9
Escitalopram tablets USP 10 MG	$281.2K	8
Citalopram tablets USP 40MG	$250.0K	5
Carbamazepine 200 MG tablets	$217.7K	6
Fenofibrate capsules USP 134 MG	$200.0K	4
Carbamazepine 200 MG USP	$200.0K	4
Escitalopram tablets USP 20MG	$190.2K	4
Citalopram tablets USP 20MG	$188.3K	4
Escitalopram tablets USP 10MG	$182.0K	4
Montelukast sodium chewable tablets 4MG	$150.0K	3
Montelukast sodium 10MG tablets	$100.0K	2
Isosorbide mononitrate er tablets	$100.0K	2
Lamotrigine tablets USP 100MG	$88.2K	2
Minocycline hcl CAPS USP 75MG 100s bt	$67.0K	3
Montelukast sodium chewable	$66.6K	2

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Citalopram	CNS & Psychiatric	$1.3M	25	0.5%	19
2	Minocycline	Advanced Antibiotics	$200.0K	4	0.9%	13
3	Isosorbide	Cardiovascular	$100.0K	2	0.2%	12

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx imports 3 pharmaceutical products across 3 categories into United States totaling $1.6M.

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx is a pharmaceutical importer based in the United States, specializing in the acquisition of finished pharmaceutical formulations from India. The company operates as a buyer, sourcing a diverse range of pharmaceutical products to meet the demands of the U.S. market. While specific details about its headquarters and parent company are not publicly disclosed, the company's role in the U.S. pharmaceutical distribution network is significant, serving as a conduit for Indian-manufactured drugs entering the American market.

The company's import activities are substantial, with a total import value of $1.6 million USD from India over 31 shipments. This volume indicates a robust engagement in the pharmaceutical trade, particularly in the importation of finished dosage forms such as tablets, capsules, syrups, and injections. The focus on finished formulations suggests a strategic approach to meet the specific needs of the U.S. healthcare system, which demands ready-to-use pharmaceutical products.

2Distribution Network

Specific information regarding Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx's warehouse locations and logistics capabilities is not publicly available. However, given the scale of its operations, it is likely that the company maintains multiple distribution centers strategically located to facilitate efficient delivery across the United States. These facilities would be equipped to handle the storage and distribution of pharmaceutical products, ensuring compliance with U.S. regulations and maintaining the integrity of the imported goods.

The company's geographic coverage extends throughout the United States, supplying pharmaceutical products to various stakeholders, including retail pharmacies, hospitals, and healthcare providers. While the primary focus is on the domestic market, the company's established import channels and logistics infrastructure may also support limited international distribution, depending on demand and regulatory considerations.

3Industry Role

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx functions as a pharmaceutical importer within the U.S. supply chain. Its role is pivotal in bridging the gap between Indian pharmaceutical manufacturers and the U.S. market, ensuring the availability of a diverse range of pharmaceutical products. By importing finished formulations, the company contributes to the enrichment of the U.S. pharmaceutical landscape, offering alternatives to domestically produced drugs and potentially influencing pricing and availability.

The company's operations also highlight the importance of international trade in pharmaceuticals, emphasizing the need for robust import channels to meet the healthcare demands of the U.S. population. Through its import activities, Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx plays a crucial role in maintaining the flow of pharmaceutical products, thereby supporting the overall health infrastructure of the United States.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx demonstrates a high level of sourcing concentration, importing exclusively from a single supplier: Torrent Pharmaceuticals Limited. This singular sourcing strategy indicates a deep reliance on Torrent Pharmaceuticals for the supply of its pharmaceutical products.

The company's portfolio is highly concentrated, with the top three products—Citalopram, Minocycline, and Isosorbide—accounting for 100% of the import value. This suggests a strategic focus on a narrow range of products, potentially to leverage Torrent Pharmaceuticals' expertise and manufacturing capabilities in these specific therapeutic areas.

While this sourcing strategy may offer benefits such as streamlined logistics and potentially favorable pricing, it also introduces risks associated with supplier dependency. Any disruptions in Torrent Pharmaceuticals' production or supply chain could directly impact Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx's ability to meet market demand. Additionally, the lack of diversification in the product portfolio may limit the company's ability to adapt to changing market needs or to mitigate risks associated with market fluctuations in specific therapeutic categories.

2Supply Chain Resilience

The resilience of Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx's supply chain is closely tied to the stability and reliability of Torrent Pharmaceuticals Limited. Given the exclusive sourcing arrangement, the company's supply chain is vulnerable to any operational challenges faced by Torrent Pharmaceuticals, including production delays, quality control issues, or regulatory compliance problems.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA's mission includes ensuring that drugs imported into the U.S. meet standards for quality, safety, and effectiveness. The Federal Food, Drug, and Cosmetic Act (FDCA) provides the legal framework governing the importation of drugs, stipulating that all drugs must be approved by the FDA before they can be legally imported and marketed in the U.S.

The FDA's regulatory framework encompasses various aspects of drug importation, including the examination of shipments, classification, and liquidation. The agency works in coordination with U.S. Customs and Border Protection (CBP) to enforce these regulations, ensuring that imported drugs comply with U.S. standards. Additionally, the FDA collaborates with other federal agencies, such as the Centers for Disease Control and Prevention (CDC), to address public health concerns related to imported products.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in the United States are stringent. Importers must ensure that all drugs meet FDA standards for quality, safety, and effectiveness. This includes obtaining the necessary approvals and registrations for each product intended for importation. The FDA does not recognize regulatory approvals from other countries; therefore, foreign manufacturers must comply with FDA requirements before their products can be imported into the U.S.

Frequently Asked Questions — Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx

What products does Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx import from India?

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx imports 3 pharmaceutical products across 3 categories. Top imports: Citalopram ($1.3M), Minocycline ($200.0K), Isosorbide ($100.0K).

Who supplies pharmaceuticals to Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx from India?

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx sources from 1 verified Indian suppliers. The primary supplier is Torrent Pharmaceuticals Limited (100.0% of imports, $2.8M).

What is Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx's total pharmaceutical import value?

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx's total pharmaceutical import value from India is $1.6M, based on 31 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx focus on?

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx imports across 3 categories. The largest: CNS & Psychiatric (80.6%), Advanced Antibiotics (12.9%), Cardiovascular (6.5%).

Get Full Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx?

What Formulations Does Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx Import?

What Products Does Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx Import?

Top Products by Import Value

Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx Therapeutic Categories — 3 Specializations